Journal
PEDIATRIC CARDIOLOGY
Volume 34, Issue 7, Pages 1532-1534Publisher
SPRINGER
DOI: 10.1007/s00246-013-0739-8
Keywords
Supraventricular tachycardia; Calcium-channel blockers; Medical knowledge
Categories
Ask authors/readers for more resources
The use of intravenous verapamil for tachyarrhythmia in infants is widely considered contraindicated due to the perceived risk of hemodynamic collapse after administration. This article reviews the relatively limited evidence that led to this well-known contraindication and highlights the interesting process by which medical practice may evolve in the absence of persuasive science.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available